Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A novel Kazal-type protease inhibitor from Aedes aegypti effective for NS2B-NS3 protease from the Zika virus and subtilases.

Archives of biochemistry and biophysics·2026

Same author

Should snakes used in antivenom production be retired? An analysis of Bothrops moojeni venom at different ages.

Toxicon : official journal of the International Society on Toxinology·2025

Same author

Length, weight, and longevity record for Micrurus frontalis (Duméril, Bibron & Duméril, 1854).

Brazilian journal of biology = Revista brasleira de biologia·2021

Same author

Novel pseudo-aspartic peptidase from the midgut of the tick Rhipicephalus microplus.

Scientific reports·2019

Same author

The Self-Assembling Peptide P<sub>11</sub>-4 Prevents Collagen Proteolysis in Dentin.

Journal of dental research·2019

Same author

A functional and thromboelastometric-based micromethod for assessing crotoxin anticoagulant activity and antiserum relative potency against Crotalus durissus terrificus venom.

Toxicon : official journal of the International Society on Toxinology·2018

Same journal

The effect of glycyrrhetinic acid on pharmacokinetics of cortisone and its metabolite cortisol in rats.

Journal of biomedicine & biotechnology·2012

Same journal

Insights and hopes in umbilical cord blood stem cell transplantations.

Journal of biomedicine & biotechnology·2012

Same journal

Three-dimensional visualization with large data sets: a simulation of spreading cortical depression in human brain.

Journal of biomedicine & biotechnology·2012

Same journal

Bioconversion of sugarcane biomass into ethanol: an overview about composition, pretreatment methods, detoxification of hydrolysates, enzymatic saccharification, and ethanol fermentation.

Journal of biomedicine & biotechnology·2012

Same journal

Trends in tissue engineering for blood vessels.

Journal of biomedicine & biotechnology·2012

Same journal

Salinomycin as a drug for targeting human cancer stem cells.

Journal of biomedicine & biotechnology·2012

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 7, 2026

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel

Published on: June 29, 2015

Thrombin inhibitors from different animals.

A M Tanaka-Azevedo¹, K Morais-Zani, R J S Torquato

¹Laboratory of Pathophysiology, Butantan Institute, Avenue Vital Brazil 1500, 05503-900 São Paulo, SP, Brazil. amt.azevedo@uol.com.br

Journal of Biomedicine & Biotechnology

|October 27, 2010

Summary

This summary is machine-generated.

This study reviews animal-derived specific thrombin inhibitors, highlighting their potential as novel antithrombotic agents to combat thromboembolic diseases. These inhibitors target thrombin, a key enzyme in blood coagulation.

More Related Videos

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

Related Experiment Videos

Last Updated: Jun 7, 2026

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel

Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel

Published on: June 29, 2015

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

Area of Science:

Biochemistry
Pharmacology
Veterinary Medicine

Background:

Thromboembolic diseases remain leading causes of death and disability in high-income nations.
Current anticoagulants target coagulation enzymes like thrombin and factor Xa.
Thrombin plays a critical role in clot formation by activating platelets and converting fibrinogen to fibrin.

Purpose of the Study:

To summarize existing and emerging research on specific thrombin inhibitors found in various animal species.
To explore the potential of these animal-derived inhibitors as novel antithrombotic therapies.

Main Methods:

Literature review of scientific publications on thrombin inhibitors in animals.
Analysis of the biochemical mechanisms and antithrombotic potential of identified inhibitors.

Main Results:

Thrombin is a validated target for anticoagulant drug development.
Selective thrombin inhibitors represent a promising class of antithrombotic agents.
Various animal species possess specific thrombin inhibitors with potential therapeutic applications.

Conclusions:

Specific thrombin inhibitors from animals warrant further investigation for antithrombotic drug development.
Understanding these natural inhibitors could lead to new strategies for managing thromboembolic disorders.